BioCentury
ARTICLE | Company News

Tapestry Pharmaceuticals cancer news

February 18, 2008 8:00 AM UTC

Tapestry began filing for Chapter 11 bankruptcy and reduced its headcount by 22 (65%) to 12. Tapestry will continue its clinical trials of TPI 287, a third-generation taxane in Phase II testing to tre...